article

1. Hypothalamic MRI-derived microstructure is associated with neurocognitive aging in humans..  Neurobiology of aging.  102-112. 2024
2. Cognitive reserve proxies are associated with age-related cognitive decline - Not age-related gait speed decline..  Neurobiology of aging.  46-54. 2024
3. Plasma proteomic profile of abdominal obesity in older adults..  Obesity (Silver Spring, Md.).  32:938-948. 2024
4. Polygenic prediction of human longevity on the supposition of pervasive pleiotropy..  medRxiv : the preprint server for health sciences.  2023
5. Organ aging signatures in the plasma proteome track health and disease..  Nature.  624:164-172. 2023
6. Challenges in catalyzing and sustaining research in translational science..  Journal of clinical and translational science.  7:-. 2023
7. Frailty Resilience Score: A Novel Measure of Frailty Resilience Associated With Protection From Frailty and Survival..  The journals of gerontology. Series A, Biological sciences and medical sciences.  78:1771-1777. 2023
8. Discovering Biological Mechanisms of Exceptional Human Health Span and Life Span..  Cold Spring Harbor perspectives in medicine.  13. 2023
9. SuperAger Initiative: unlocking the genetic potential of exceptional longevity..  Nature aging.  3:627-628. 2023
10. Biological Age Acceleration and Motoric Cognitive Risk Syndrome..  Annals of neurology.  93:1187-1197. 2023
11. Cognition, function, and prevalent dementia in centenarians and near-centenarians: An individual participant data (IPD) meta-analysis of 18 studies..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  19:2265-2275. 2022
12. Age-related changes in gait domains: Results from the LonGenity study..  Gait & posture.  8-13. 2022
13. Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort survey..  Cerebral circulation - cognition and behavior.  -. 2022
14. Looking at IGF-1 through the hourglass..  Aging.  14:6379-6380. 2022
15. A metabolomic signature of the APOE2 allele..  GeroScience.  45:415-426. 2022
16. Integrity of hypothalamic-pituitary-testicular axis in exceptional longevity..  Aging cell.  21:-. 2022
17. Relative Trajectories of Gait and Cognitive Decline in Aging..  The journals of gerontology. Series A, Biological sciences and medical sciences.  77:1230-1238. 2022
18. Rare genetic coding variants associated with human longevity and protection against age-related diseases..  Nature aging.  1:783-794. 2021
19. Extending human healthspan and longevity: a symposium report..  Annals of the New York Academy of Sciences.  1507:70-83. 2021
20. Einstein-Nathan Shock Center: translating the hallmarks of aging to extend human health span..  GeroScience.  43:2167-2182. 2021
21. The antagonistic pleiotropy of insulin-like growth factor 1..  Aging cell.  20:-. 2021
22. Trajectories of frailty in aging: Prospective cohort study..  PloS one.  16:-. 2021
23. A Compendium of Age-Related PheWAS and GWAS Traits for Human Genetic Association Studies, Their Networks and Genetic Correlations..  Frontiers in genetics.  -. 2021
24. Common diseases alter the physiological age-related blood microRNA profile..  Nature communications.  11:-. 2020
25. Plasma proteomic profile of age, health span, and all-cause mortality in older adults..  Aging cell.  19:-. 2020
26. Similar burden of pathogenic coding variants in exceptionally long-lived individuals and individuals without exceptional longevity..  Aging cell.  19:-. 2020
27. Plasma proteomic profile of frailty..  Aging cell.  19:-. 2020
28. Genetics of extreme human longevity to guide drug discovery for healthy ageing..  Nature metabolism.  2:663-672. 2020
29. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults..  Cells.  9. 2020
30. Undulating changes in human plasma proteome profiles across the lifespan..  Nature medicine.  25:1843-1850. 2019
31. Frailty and Risk of Incident Motoric Cognitive Risk Syndrome..  Journal of Alzheimer's disease : JAD.  71:S85-S93. 2019
32. 40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain..  Journal of molecular endocrinology.  61:T171-T185. 2018
33. Genetic Insights Into Frailty: Association of 9p21-23 Locus With Frailty..  Frontiers in medicine.  -. 2018
34. Association between Sleep Patterns and Health in Families with Exceptional Longevity..  Frontiers in medicine.  -. 2017
35. The role of dietary patterns and exceptional parental longevity in healthy aging..  Nutrition and healthy aging.  4:247-254. 2017
36. Association of Family History of Exceptional Longevity With Decline in Physical Function in Aging..  The journals of gerontology. Series A, Biological sciences and medical sciences.  72:1649-1655. 2017
37. Effect of Exceptional Parental Longevity and Lifestyle Factors on Prevalence of Cardiovascular Disease in Offspring..  The American journal of cardiology.  120:2170-2175. 2017
38. Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population..  Neurobiology of aging.  238.e1-238.e8. 2017
39. Symptoms of Apathy Independently Predict Incident Frailty and Disability in Community-Dwelling Older Adults..  The Journal of clinical psychiatry.  78:e529-e536. 2017
40. Lower circulating insulin-like growth factor-I is associated with better cognition in females with exceptional longevity without compromise to muscle mass and function..  Aging.  8:2414-2424. 2016
41. Strategies and Challenges in Clinical Trials Targeting Human Aging..  The journals of gerontology. Series A, Biological sciences and medical sciences.  71:1424-1434. 2016
42. Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity..  Journal of the American Geriatrics Society.  64:1583-91. 2016
43. The Somatotropic Axis in Human Aging: Framework for the Current State of Knowledge and Future Research..  Cell metabolism.  23:980-989. 2016
44. Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span..  Cold Spring Harbor perspectives in medicine.  6:-. 2015
45. The influence of gender on inheritance of exceptional longevity..  Aging.  7:412-8. 2015
46. MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL..  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.  21:590-4. 2015
47. Association of exceptional parental longevity and physical function in aging..  Age (Dordrecht, Netherlands).  36:-. 2014
48. GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence..  Diabetologia.  57:1623-34. 2014
49. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity..  Aging cell.  13:769-71. 2014
50. Individuals with exceptional longevity manifest a delayed association between vitamin D insufficiency and cognitive impairment..  Journal of the American Geriatrics Society.  62:153-8. 2014
51. Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity..  Current vascular pharmacology.  12:690-7. 2014
52. Opioid receptor blockade prevents exercise-associated autonomic failure in humans..  Diabetes.  61:1609-15. 2012
53. Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation..  The Journal of clinical endocrinology and metabolism.  97:623-31. 2011
54. Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus..  The Journal of clinical endocrinology and metabolism.  96:3424-31. 2011
55. Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125..  Thyroid : official journal of the American Thyroid Association.  21:913-6. 2011
56. Mechanisms of vascular complications in prediabetes..  The Medical clinics of North America.  95:309-25, vii. 2011
57. Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism..  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.  17:104-7. 2011